Analysis

PDD Holdings Inc. (PDD) Q4 2025 Earnings: Key Takeaways

PDD Holdings Inc. (PDD) Q4 2025 Earnings: Key Takeaways

Growth at a cost. PDD Holdings delivered Q4 2025 revenue of ¥123.91 billion, marking 12.0% year-over-year growth, but the top-line…

Salesforce CRM FY27 Strategy: Financial Analysis and Market Position

Date: 25/03/2026 Introduction Salesforce Inc. (NYSE: CRM) is poised to navigate fiscal year 2027 with a strategic focus on three…

Intrusion Inc. (INTZ) Q4 2025 Earnings: What Went Wrong

Intrusion Inc. missed Q4 earnings expectations by a substantial margin, though the miss obscures a more complex story of contract…

KB Home (KBH) Q1 2026 Earnings: What Went Wrong

KB Home stumbled in its fiscal first quarter, missing consensus estimates as a deteriorating housing market environment compressed both volumes…

LightInTheBox Holding Co., Ltd. (LITB) Q4 2025 Earnings: Key Takeaways

LightInTheBox delivered a powerful profitability inflection in Q4 2025, with adjusted EPS surging 800.0% year-over-year to $0.18 as the e-commerce…

Broadcom (AVGO) targets long-term growth on hyperscaler deals and AI chip demand

Broadcom Inc. (NASDAQ: AVGO) is positioning for sustained growth as hyperscale customers increase spending on AI infrastructure and networking silicon.…

M-tron Industries, Inc. 2025 Financial Results

Company Overview M-tron Industries, Inc. is a U.S.-based designer and manufacturer of highly-engineered electronic components for the aerospace, defense, avionics,…

Reed’s, Inc. 2025 Financial Review

Company Overview Reed's, Inc. is a leading provider of natural, handcrafted craft beverages, operating under the Reed’s, Virgil’s, and Flying…

Compass Pathways 2025 Financial Review

Company Overview Compass Pathways plc is a biotechnology company developing COMP360, an investigational synthetic psilocybin therapy for mental health conditions…

LENZ Therapeutics Q4 FY 2025 Financial Update

Company Overview LENZ Therapeutics is a pharmaceutical company focused on the commercialization of VIZZ (aceclidine ophthalmic solution) 1.44% for the…